Accelerate Diagnostics Files for Chapter 11 Protection, Plans Major Asset Sale Accelerate Diagnostics has initiated Chapter 11 proceedings and agreed to a major asset sale. This strategic move aims to ensure liquidity and operational stability during restructuring.

Accelerate Diagnostics Files for Chapter 11 Protection, Plans Major Asset Sale #United_States #Tucson #Chapter_11 #Accelerate_Diagnostics #Indaba_Capital

Accelerate Diagnostics Submits New System for FDA Approval to Combat Antimicrobial Resistance Accelerate Diagnostics has submitted its innovative WAVE System for FDA clearance, aimed at rapid testing for antimicrobial susceptibility in blood cultures.

Accelerate Diagnostics Submits New System for FDA Approval to Combat Antimicrobial Resistance #United_States #Tucson #Antimicrobial_Resistance #Accelerate_Diagnostics #WAVE_System

Accelerate Diagnostics Reports Financial Results for Q4 and Full Year 2024 Accelerate Diagnostics, Inc. has shared its financial outcomes for the fourth quarter and the entire year of 2024, revealing challenges and efforts in their operations.

Accelerate Diagnostics Reports Financial Results for Q4 and Full Year 2024 #USA #financial_results #Tucson #Q4_2024 #Accelerate_Diagnostics

Accelerate Diagnostics Reveals Q4 and Full-Year 2024 Preliminary Results with Promising Innovations Accelerate Diagnostics has announced its preliminary results for Q4 and full-year 2024, showcasing progress in clinical trials and financial metrics.

Accelerate Diagnostics Reveals Q4 and Full-Year 2024 Preliminary Results with Promising Innovations #USA #Tucson #Accelerate_Diagnostics #Gram-Negative #Pheno_System